Sign up for free insights newsletter
60

Shanghai Pharmaceuticals Holding Co Ltd

601607SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥16.47
-2.49%
End of day
Market Cap

$63.78B

P/E Ratio

11.24

Employees

49,402

Dividend Yield

2.37%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.76-1.17-1.43
Calmar-1.58-0.89-1.20
Sharpe-1.44-0.90-1.14
Omega0.720.830.78
Martin-4.07-1.88-2.85
Ulcer4.117.325.89

Shanghai Pharmaceuticals Holding Co Ltd (601607) Price Performance

Shanghai Pharmaceuticals Holding Co Ltd (601607) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CNY16.47, down 2.49% from the previous close.

Over the past year, 601607 has traded between a low of CNY16.47 and a high of CNY19.48. The stock has lost 13.3% over this period. It is currently 15.5% below its 52-week high.

Shanghai Pharmaceuticals Holding Co Ltd has a market capitalization of $63.78B, with a price-to-earnings ratio of 11.24 and a dividend yield of 2.37%.

About Shanghai Pharmaceuticals Holding Co Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$280.69B
EBITDA
$9.46B
Profit Margin
2.01%
EPS (TTM)
1.53
Book Value
20.44

Technical Indicators

52 Week High
CN¥19.68
52 Week Low
CN¥16.29
50 Day MA
CN¥17.33
200 Day MA
CN¥18.04
Beta
0.33

Valuation

Trailing P/E
11.24
Forward P/E
17.21
Price/Sales
0.23
Price/Book
0.85
Enterprise Value
$66.83B